Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 29% ± 14% | |
glutamatergic neuron | 3 studies | 22% ± 9% |
Insufficient scRNA-seq data for expression of TAF13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1121.37 | 1445 / 1445 | 100% | 49.80 | 183 / 183 |
uterus | 100% | 683.48 | 170 / 170 | 100% | 77.39 | 459 / 459 |
brain | 100% | 1585.73 | 2641 / 2642 | 100% | 84.36 | 705 / 705 |
breast | 100% | 988.37 | 459 / 459 | 100% | 72.30 | 1114 / 1118 |
liver | 100% | 912.89 | 226 / 226 | 100% | 42.21 | 404 / 406 |
lung | 99% | 947.71 | 574 / 578 | 100% | 70.00 | 1155 / 1155 |
thymus | 100% | 834.23 | 651 / 653 | 99% | 51.43 | 601 / 605 |
prostate | 100% | 959.06 | 244 / 245 | 99% | 65.89 | 499 / 502 |
kidney | 100% | 1067.35 | 89 / 89 | 99% | 43.46 | 888 / 901 |
bladder | 100% | 961.05 | 21 / 21 | 98% | 60.99 | 496 / 504 |
intestine | 100% | 979.89 | 966 / 966 | 98% | 47.76 | 515 / 527 |
stomach | 100% | 873.92 | 359 / 359 | 98% | 44.14 | 279 / 286 |
skin | 100% | 1274.70 | 1807 / 1809 | 97% | 71.35 | 459 / 472 |
pancreas | 97% | 454.59 | 317 / 328 | 100% | 58.64 | 178 / 178 |
adrenal gland | 100% | 987.59 | 258 / 258 | 95% | 38.06 | 218 / 230 |
ovary | 93% | 396.05 | 167 / 180 | 100% | 42.48 | 430 / 430 |
blood vessel | 100% | 1181.66 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.41 | 29 / 29 |
muscle | 100% | 1617.99 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 619.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 73.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 44.00 | 1 / 1 |
adipose | 100% | 1152.31 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 1042.04 | 847 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 21.44 | 55 / 80 |
peripheral blood | 66% | 347.71 | 617 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051123 | Biological process | RNA polymerase II preinitiation complex assembly |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0060261 | Biological process | positive regulation of transcription initiation by RNA polymerase II |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0006352 | Biological process | DNA-templated transcription initiation |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005669 | Cellular component | transcription factor TFIID complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0003677 | Molecular function | DNA binding |
GO_0017025 | Molecular function | TBP-class protein binding |
GO_0016251 | Molecular function | RNA polymerase II general transcription initiation factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TAF13 |
Protein name | TATA-box binding protein associated factor 13 TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) |
Synonyms | TAFII18 TAF2K |
Description | FUNCTION: The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription . TFIID recognizes and binds promoters via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) . The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 . TAF13, together with TAF11 and TBP, play key roles during promoter binding by the TFIID and TFIIA transcription factor complexes . . |
Accessions | A0A8J9AJQ9 Q0VA92 Q15543 ENST00000338366.6 ENST00000692048.1 ENST00000461096.7 A0A8I5KR19 |